These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9267696)
1. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Candeliere GA; Roughley PJ; Glorieux FH Bone; 1997 Aug; 21(2):201-6. PubMed ID: 9267696 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues. Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M J Mol Diagn; 2000 May; 2(2):67-72. PubMed ID: 11272890 [TBL] [Abstract][Full Text] [Related]
3. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. Shenker A; Weinstein LS; Sweet DE; Spiegel AM J Clin Endocrinol Metab; 1994 Sep; 79(3):750-5. PubMed ID: 8077356 [TBL] [Abstract][Full Text] [Related]
4. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia. Lietman SA; Ding C; Levine MA J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125 [TBL] [Abstract][Full Text] [Related]
5. Activating mutations of Gs protein in monostotic fibrous lesions of bone. Alman BA; Greel DA; Wolfe HJ J Orthop Res; 1996 Mar; 14(2):311-5. PubMed ID: 8648511 [TBL] [Abstract][Full Text] [Related]
6. Searching for Arg201 mutations in the GNAS1 gene in Italian patients with McCune-Albright syndrome. de Sanctis L; Romagnolo D; Greggio N; Genitori L; Lala R; de Sanctis C J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():883-9. PubMed ID: 12199346 [TBL] [Abstract][Full Text] [Related]
7. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone? Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases. Lee SE; Lee EH; Park H; Sung JY; Lee HW; Kang SY; Seo S; Kim BH; Lee H; Seo AN; Ahn G; Choi YL Hum Pathol; 2012 Aug; 43(8):1234-42. PubMed ID: 22245114 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia. Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. Candeliere GA; Glorieux FH; Prud'homme J; St-Arnaud R N Engl J Med; 1995 Jun; 332(23):1546-51. PubMed ID: 7739708 [TBL] [Abstract][Full Text] [Related]
11. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome. Weinstein LS J Bone Miner Res; 2006 Dec; 21 Suppl 2():P120-4. PubMed ID: 17229000 [TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular basis of fibrous dysplasia. Marie PJ Histol Histopathol; 2001 Jul; 16(3):981-8. PubMed ID: 11510989 [TBL] [Abstract][Full Text] [Related]
14. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion. Malchoff CD; Reardon G; MacGillivray DC; Yamase H; Rogol AD; Malchoff DM J Clin Endocrinol Metab; 1994 Mar; 78(3):803-6. PubMed ID: 8126161 [TBL] [Abstract][Full Text] [Related]
15. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Marie PJ; de Pollak C; Chanson P; Lomri A Am J Pathol; 1997 Mar; 150(3):1059-69. PubMed ID: 9060842 [TBL] [Abstract][Full Text] [Related]
16. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. Shenker A; Weinstein LS; Moran A; Pescovitz OH; Charest NJ; Boney CM; Van Wyk JJ; Merino MJ; Feuillan PP; Spiegel AM J Pediatr; 1993 Oct; 123(4):509-18. PubMed ID: 8410501 [TBL] [Abstract][Full Text] [Related]
17. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Schwindinger WF; Francomano CA; Levine MA Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5152-6. PubMed ID: 1594625 [TBL] [Abstract][Full Text] [Related]
18. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469 [TBL] [Abstract][Full Text] [Related]
19. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. Idowu BD; Al-Adnani M; O'Donnell P; Yu L; Odell E; Diss T; Gale RE; Flanagan AM Histopathology; 2007 May; 50(6):691-704. PubMed ID: 17493233 [TBL] [Abstract][Full Text] [Related]
20. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. Yamamoto T; Ozono K; Kasayama S; Yoh K; Hiroshima K; Takagi M; Matsumoto S; Michigami T; Yamaoka K; Kishimoto T; Okada S J Clin Invest; 1996 Jul; 98(1):30-5. PubMed ID: 8690800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]